Background Human adenoviruses (HAdVs) are a frequent cause of respiratory tract infections in children; however, their epidemiological patterns and genomic diversity remain insufficiently characterized in Europe. As respiratory HAdVs can cause outbreaks of acute and severe disease and show periodic re-emergence, improved understanding of their circulation is needed. Aim To investigate the epidemiology, age distribution, and genomic diversity of respiratory HAdVs in pediatric patients in Île-de-France during the first half of 2022. Methods We retrospectively analyzed 6,956 respiratory samples from patients <18 years, collected at five hospitals (Jan–June 2022). HAdVs were detected by multiplex PCR. Viral loads were quantified in mono-infections, and whole-genome sequencing was performed on samples with sufficient viral load. Results HAdVs were detected in 14% of samples, making them the second most prevalent virus after rhinovirus/enterovirus. Co-infections were frequent (64%), particularly in younger children. Among the 254 mono-infected samples with viral-load quantification, 110 (43%) had low or undetectable viral loads. WGS of 122 samples revealed HAdV species B (62.3%), C (34.4%), and F (3.3%). Species distribution varied by age: HAdV-C predominated in children under 2 years, while HAdV-B was more common in older children. The most frequent genotypes were B3 (76.3%), B66 (18.4%), and B7d (5.3%) within species B, and C1 (33.3%), C89 (26.2%), and C2 (23.8%) within species C. Conclusion HAdVs are prevalent among children with respiratory infections, with age-specific patterns and substantial genomic diversity. The circulation of diverse genotypes, including recombinants and potentially more virulent variants, highlights the importance of sustained molecular surveillance.
No takes yet. Share an insight, caveat, or question.
Salmona et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: